Brain natriuretic peptide in decompensation of liver cirrhosis in non-cardiac patients

Hepato-Gastroenterology

Volumn 56, Issue 89, 2009, Pages 181-185

  Radvan, Martin ^a,d   Svoboda, Petr ^b   Radvanová, Jana ^a   Štumar, Josef ^a   Scheer, Peter ^c  

^a Hospital Trebic   (Czech Republic)

^b Traumatological Hospital of Brno   (Czech Republic)

^c UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^d NONE   (Czech Republic)

Author keywords

Ascites; Brain natriuretic peptides; Cardiomyopathy; Cirrhosis

Indexed keywords

ALBUMIN; BILIRUBIN; BRAIN NATRIURETIC PEPTIDE; CREATININE; SODIUM;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HUMAN; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 64949118102     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sherlock S, Dooley J: Disease of the Liver and Biliary System. 11th vol. Oxford: Blackwell Publishing Company 2002; 365-378.
2. Naveau S, Perlemuter G, Balian A: Epidemiology and natural history of cirrhosis. Rev Prat 2005; 55(14):1527-1532.
3. Goncelvesova E: Merit of natriuretic peptides for diagnosis, prognosis, management and therapy of heart failure. Interni med 2006; 8:428-430.
4. Knudsen CW, Riis JS, Finsen AV et al: Diagnostic value of a rapid test for B-type natriuretic peptide in patients presenting with acute dyspnoea: effect of age and gender. Eur J Heart Fail 2004; 6:55-62.
5. Mair J, Hammerer-Lercher A, Puschendorf B: The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001; 39:571-588.
6. Weber T, Auer J, Eber B: The diagnostic and prognostic value of brain natriuretic peptide and aminoterminal (nt)-pro brain natriuretic peptide. Curr Pharm Des 2005; 11:511-525.
7. Jensen KT, Carstens J, Ivarsen P et al: A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997; 57:529-540.
8. Horl WH: Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy. J Investig Med 2005; 53:366-370.
9. Shor R, Rozenman Y, Bolshinsky A et al: BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med 2006; 17:536-540.
10. Ueda S, Nishio K, Akai Y et al: Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock. Shock 2006; 26:134-139.
11. Yildiz R, Yildirim B, Karincaoglu M et al: Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol 2005; 20:1115-1120.
12. Wambach G, Koch J: BNP plasma levels during acute volume expansion and chronic sodium loading in normal men. Clin Exp Hypertens 1995; 17:619-629.
13. Kamath PS, Wiesner RH, Malinchoc M et al: A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:473-475.
14. Heuman DM, Abou-Assi SG, Habib A et al: Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD score who are at high risk for early death. Hepatology 2004; 40:802-810.
15. Lenaerts A, Codden T, Meunier JC: Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system. Hepatology 2006; 44:844-849.
16. Salo J, Jimenez W, Kuhn M et al: Urinary excretion of urodilatin in patients with cirrhosis. Hepatology 1996; 24:1428-1432.
17. La Villa G, Riccardi D, Lazzeri C et al: Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites to avid sodium retention. Hepatology 1995; 22:1745-1750.
18. Iwao T, Oho K, Nakano R et al: High plasma cardiac natriuretic peptides associated with enhanced cyclic guanosine monophosphate in preascitic cirrhosis. J Hepatol 2000; 32:426-433.
19. Henriksen JH, Gotze JP, Fuglsang S et al: Increased circulating pro-brain natriuretic peptide (pro BNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 2003; 52:1511-1517.
20. Wong F, Siu S, Liu, P et al: Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? Clin Sci (London) 2001; 101:621-628.
21. Kuse ER, Meyer M, Constantin R et al: Urodilatin (INN: ularitide). A new peptide in the treatment of acute kidney failure following liver transplantation. Anaesthesist 1996; 45:351-358.
22. Akamatsu A, Sugawara Y, Tamura S et al: Prevention of renal impairment by continuous infusion of human atrial natriuretic peptide after liver transplantation. Transplantation 2005; 80:1093-1098.